Xinjiang Medical University Affiliated Cancer Hospital
Welcome,         Profile    Billing    Logout  
 0 Trials 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sun, Yonghong
TQB2102-II-04, NCT06767800: A Clinical Trial Evaluating TQB2102 for Injection in Combination With Benmelstobart/Penpulimab With or Without Capecitabine in Unresectable Locally Advanced, Recurrent, or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastroesophageal Adenocarcinoma

Not yet recruiting
2
168
RoW
TQB2102 for injection+Benmelstobart, TQB2102 for injection+Benmelstobart+Capecitabine
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Gastroesophageal Adenocarcinoma
09/26
09/27
Jiang, Renbing
TQB2916-AK105-II-01, NCT06500091: TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors

Not yet recruiting
2
54
RoW
TQB2916 injection + doxorubicin hydrochloride for injection, TQB2916 injection+penpulimab injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Soft Tissue Sarcoma, Melanoma
06/26
12/26

Download Options